|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Assessment of endothelial function in patients with nonalcoholic fatty liver disease显示文摘 | Yasar Colak Ebubekir Senates Atakan Yesil Yusuf Yilmaz Oguzhan Ozturk Levent Doganay Ender Coskunpinar Ozlem Timirci Kahraman Banu Mesci Celal Ulasoglu Ilyas Tuncer | 2013 | Endocrine2013,,1: | 2 |
| 2 | Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘 | Akbas F Coskunpinar E Aynaci E | 2012 | Exp Lung Res2012,38,6: | 1 |
| 3 | The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome-wide expression study 显示文摘 | Cakmak HA Coskunpinar E Ikitimur B | 2015 | J Cardiovasc Med (Hagerstown)2015,16,6: | 1 |
| 4 | Investigation of some DNA repair genes association in non small cell lung cancer 显示文摘 | Coskunpinar E Yildiz P Aynaci E | | Cellular and Molecular Biology (Noisy-le- Grand France) 20!50,61,8: | 1 |
| 5 | Analysis of serum micro- RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘 | Akbas F Coskunpinar E Aynaci E | 2012 | Exp Lung Res2012,38,6: | 1 |
| 6 | Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘 | Akbas F Coskunpinar E Aynaci E | 2012 | Exp Lung Res2012,38,: | 1 |
| 7 | Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘 | Akbas F Coskunpinar E Aynaci E | 2012 | Exp Lung Res2012,38,6: | 1 |
| 8 | The prognostic value of circulating microRNAs in heart failure:preliminary results from a genome-wide expression study显示文摘 | Cakmak HA Coskunpinar E Ikitimur B | 2015 | J Cardiovasc Med2015,16,6: | 1 |
| 9 | Identification of a dif- ferential expression signature associated with tumorigenesis and metastasis of laryngealcarcinoma显示文摘 | Coskunpinar E Oltulu YM Orhan KS | 2014 | Gene2014,534,2: | 1 |
| 10 | ANALYSIS OF SERUM MICRO-RNAs AS POTENTIAL BIOMARKER IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE显示文摘 | Fahri Akbas Ender Coskunpinar Engin Aynac&inodot Yasemin Mü steri Oltulu Pinar Yildiz | 2012 | Experimental Lung Research2012,,: | 1 |
| 11 | Analysis of se- rum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease显示文摘 | AKBAS F COSKUNPINAR E AYNACI E | 2012 | Exp Lung Res2012,38,6: | 1 |
| 12 | Association between survivin gene promoter -31G/C and -644C/T polymorphisms and non-small cell lung cancer显示文摘 | Aynaci E Coskunpinar E Eren A | 2013 | Genet Mol Res2013,12,3: | 1 |
| 13 | Measurement of constructs using self-report and behavioral lab tasks: Is there overlap in nomothetic span and construct representation for impulsivity?显示文摘 | Cyders M A Coskunpinar A | 2011 | Clinical Psychology Review2011,31,6: | 1 |
| 14 | Cyelooxygenase-2 gene and lung carcinoma risk显示文摘 | Coskunpinar E Eraltan IY Turna A | 2011 | Med Oncol2011,28,4: | 1 |
| 15 | The relationship between self - re- port and lab task conceptualizations of impulsivity 显示文摘 | Cyders M A and A Coskunpinar | 2012 | Journal of Re- search in Personality2012,46,1: | 1 |
| 16 | Increased serum soluble lectin-like oxidized low-density lipoprotein receptor-1 levels in patients with biopsy-proven nonalcoholic fatty liver disease显示文摘AIM: To analyze the relationship between the serum lectin-like oxidized low-density lipoprotein receptor-1(LOX-1) levels and clinical and histopathological features of biopsy-confirmed nonalcoholic fatty liver disease(NAFLD) patients.METHODS: Fifty-three consecutive,biopsy-proven NAFLD patients(31 males and 22 females,mean age 42.5 ± 9.6 years) and 26 age- and gender-matched,healthy controls(14 males and 12 females,mean age 39 ± 10.7 years) were included.The patientswith NAFLD were consecutive patients who had been admitted to the hepatology outpatient clinic within the last year and had been diagnosed with NAFLD as the result of liver biopsy.The healthy controls were individuals who attended the outpatient clinic for routine health control and had no known chronic illnesses.The histological evaluation was conducted according t o t he N AF LD ac t ivi ty scoring syst em recommended by The National Institute of Diabetes and Digestive and Kidney Diseases Nonalcoholic Steatohepatitis Clinical Research Network.The serum LOX-1 levels were measured using an ELISA kit(Life Science Inc.USCN.Wuhan,Catalog No.E1859Hu) in both patients and healthy controls.A receiver operating characteristic(ROC) curve analysis was used to identify the optimal cutoff value of LOX-1 and thereby distinguish between patients with nonalcoholic steatohepatitis(NASH) and healthy controls.A P-value < 0.05 was considered statistically significant.RESULTS: NAFLD and healthy control groups were similar in terms of age and sex.NAFLD patients consisted of 8 patients with simple steatosis(15%),27 with borderline NASH(51%) and 18 with definitive NASH(34%).Metabolic syndrome was found in 62.2% of the patients with NAFLD.The mean serum LOX-1 level in biopsy-proven NAFLD patients was 8.49 ± 6.43 ng/m L compared to 4.08 ± 4.32 ng/m L in healthy controls(P = 0.001).The LOX-1 levels were significantly different between controls,simple steatosis and NASH(borderline+definite) cases(4.08 ± 4.32 ng/m L,6.1 ± 6.16 ng/m L,8.92 ± 6.45 ng/m L,respectively,P = 0.004).When the cut-off value for the serum LOX-1 level was set at 5.35 ng/m L,and a ROC curve analysis was performed to distinguish between steatohepatitis patients and controls; the sensitivity and specificity of the serum LOX-1 level were 69.8% and 69.2%,respectively.CONCLUSION: The serum LOX-1 levels were significantly higher in NAFLD patients than in healthy controls.Additionally,the serum LOX-1 levels could differentiate between steatohepatitis patients and healthy controls. | Oguzhan Ozturk Yasar Colak Ebubekir Senates Yusuf Yilmaz Celal Ulasoglu Levent Doganay Seyma Ozkanli Yasemin Musteri Oltulu Ender Coskunpinar Ilyas Tuncer | 2015 | World Journal of Gastroenterology2015,21,26: | 0 |